(Total Views: 142)
Posted On: 02/01/2022 1:51:53 PM
Post# of 107319
$CTSO News Article - First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb to Restore Hemodynamic Stability in Patients with Refractory Septic Shock https://marketwirenews.com/news-releases/firs...19198.html
(0)
(0)
My Twitter: WhyteStocks
